SCHEMBL22316082

SCHEMBL22316082

CCOC(=O)[C@@H](CCC(=O)O)NC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.50
KMT2A Q03164 2/20 0.47
POLB P06746 1/20 0.47
ANPEP P15144 1/20 0.44
ENPEP Q07075 1/20 0.44
FOLH1 Q04609 3/20 0.42
NAALAD2 Q9Y3Q0 2/20 0.42
RIMKLA Q8IXN7 1/20 0.42
GABRP O00591 2/20 0.42
GABRD O14764 2/20 0.42
GABRA1 P14867 2/20 0.42
GABRB1 P18505 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRA3 P34903 2/20 0.42
GABRA2 P47869 2/20 0.42
GABRB2 P47870 2/20 0.42
GABRA4 P48169 2/20 0.42
GABRE P78334 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28539939 1.00 L3MBTL1 (0.50) L3MBTL1KMT2APOLBANPEPENPEP
SCHEMBL13099456 0.85 L3MBTL1 (0.69) L3MBTL1KMT2APOLBCADNOD1
SCHEMBL13108405 0.85 L3MBTL1 (0.69) L3MBTL1KMT2APOLBCADNOD1
SCHEMBL17343482 0.85 L3MBTL1 (0.50) L3MBTL1KMT2APOLBCADNOD1
SCHEMBL14497500 0.84 ANPEP (0.47) ANPEPENPEPFOLH1NAALAD2RIMKLA
SCHEMBL20603880 0.84 ANPEP (0.47) ANPEPENPEPFOLH1NAALAD2RIMKLA
SCHEMBL12207450 0.84 ANPEP (0.47) ANPEPENPEPFOLH1NAALAD2RIMKLA
SCHEMBL19422704 0.83 L3MBTL1 (0.57) L3MBTL1KMT2APOLBCADNOD1
SCHEMBL461495 0.83 L3MBTL1 (0.49) L3MBTL1KMT2APOLBFOLH1CAD
SCHEMBL11124586 0.81 L3MBTL1 (0.56) L3MBTL1KMT2APOLBFOLH1NAALAD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same Sumitomo Pharma Co., Ltd. (JP) 2024-06-25 US disclosed
US-20200247845-A1 Hemiasterlin Derivatives and Antibody-Drug Conjugates Including Same SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200247845-A1 Hemiasterlin Derivatives and Antibody-Drug Conjugates Including Same FCGRT, QARS1, INHA L3MBTL1 4119/4885KMT2A 496/4885POLB 3604/4885
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same FCGRT, QARS1, INHA L3MBTL1 4119/4885KMT2A 496/4885POLB 3604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.